Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Synairgen
Synairgen
BMS, Synairgen Regroup After Trials Miss Primary Endpoints
BioSpace
Mon, 05/16/22 - 10:36 am
Bristol Myers Squibb
NCT03036098
Opdivo-Yervoy
metastatic urothelial carcinoma
clinical trials
Synairgen
Synairgen slumps as inhaled COVID drug fails pivotal test
Pharmaforum
Tue, 02/22/22 - 10:42 am
Synairgen
SNG001
COVID-19
Edesa finds a signal in severely ill Covid-19 patients
EP Vantage
Tue, 09/21/21 - 11:01 pm
Edesa Biotech
COVID-19
Sorrento Therapeutics
Synairgen
Implicit Bioscience
Atriva Therapeutics
Veru
The big Covid-19 trials still to report
EP Vantage
Wed, 02/17/21 - 10:48 am
COVID-19
clinical trials
Roche
Actemra
GSK
Synairgen
Algernon
Abivax
Corbus
Synairgen’s inhaled drug cuts chances of COVID-19 progressing
Pharmaforum
Mon, 07/20/20 - 10:27 am
Synairgen
COVID-19
SNG001
interferon beta
clinical trials
AstraZeneca halts asthma study in blow to Synairgen
BioPharma Dive
Wed, 10/12/16 - 11:19 pm
AstraZeneca
asthma
Synairgen
clinical trials
AZD9412
AstraZeneca Boosts Pipeline with $232 Million Synairgen Deal
Yahoo/Zacks
Sat, 06/14/14 - 09:18 am
AstraZeneca
Synairgen
SNG001
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Yahoo/Reuters
Thu, 06/12/14 - 09:30 am
AstraZeneca
Synairgen
asthma
SNG001